Profile Image
Kevin Barton Photo
Name
Kevin Barton
Degree
M.D.
Rank
Professor
Primary Department
Hematology/Oncology
Appointment Request
Request an Appointment
Specialties
Brain Tumors
Cancers of the Blood and Blood Cells
Leukemia
Non-Hodgkin's Lymphoma
Multiple Myeloma
Refractory Lymphoma
Relapsed Lymphoma
Amyloidosis
Locations
Cardinal Bernardin Cancer Center
Loyola Center for Health at Burr Ridge
Certifications
American Board of Internal Medicine
American Board of Internal Medicine Subspecialty Hematology
Education
Medical School
The Ohio State University College of Medicine and Public Health
Residencies
University of Chicago Hospitals and Clinics, Internal Medicine: General
Fellowships
University of Chicago Hospitals and Clinics, Internal Medicine: Hematology & Medical Oncology
Hobbies
Astronomy
Publications
Grahnke,K. A.; Heiferman,D. M.; Borys,E.; Melian,E.; Barton,K. P.; Lukas,R. V.; Shaikh,N.; Leonetti,J. P.; Anderson,D. E.Delayed leptomeningeal metastasis of an adult anaplastic pilocytic astrocytoma BRAIN TUMOR PATHOLOGY 2018 ; :
Prabhu,V. C.; Melian,E.; Germanwala,A. V.; Solanki,A. A.; Borys,E.; Barton,K.; Anderson,D. E.Cranial Base Meningiomas World neurosurgery 2018 ;109:258-262
Prabhu,V. C.; Barton,K. P.; Walsh,S.; Borys,E.; Melian,E.Recurrent Malignant Gliomas: Treatment Options and their Effect on Patient's Quality of Life World neurosurgery 2017 ; :
Prabhu,V. C.; Melian,E.; Germanwala,A. V.; Solanki,A. A.; Borys,E.; Barton,K.; Anderson,D. E.Cranial Base Meningiomas World neurosurgery 2017 ; :
Bahar,B.; Barton,K.; Kini,A. R.The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms Leukemia research reports 2016 ;6:27-28
Persky,D. O.; Miller,T. P.; Unger,J. M.; Spier,C. M.; Puvvada,S.; Stea,B. D.; Press,O. W.; Constine,L. S.; Barton,K. P.; Friedberg,J. W.; LeBlanc,M.; Fisher,R. I.Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313 Blood 2015 ;125(2):236-241
Nand,S.; Barton,K.; Schultz,R.; Klein,M.; Kini,A.Heckathorn disease revisited Blood 2014 ;123(9):1429-1431
Stiff,P. J.; Unger,J. M.; Cook,J. R.; Constine,L. S.; Couban,S.; Stewart,D. A.; Shea,T. C.; Porcu,P.; Winter,J. N.; Kahl,B. S.; Miller,T. P.; Tubbs,R. R.; Marcellus,D.; Friedberg,J. W.; Barton,K. P.; Mills,G. M.; LeBlanc,M.; Rimsza,L. M.; Forman,S. J.; Fisher,R. I.Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma The New England journal of medicine 2013 ;369(18):1681-1690
Prabhu,V.; Khaldi,A.; Barton,K.; Melian,E.; Schneck,M. J.; Primeau,M.; Lee,J. M.Management of diffuse low-grade cerebral gliomas. Neurology Clinics 2010 ;28(4):1037-1059
Higa,B.; Alkan,S.; Barton,K.; Velankar,M.Precursor B-cell acute lymphoblastic leukaemia with FAB L3 (i.e., Burkitt's leukaemia/lymphoma) morphology and co-expression of monoclonal surface light chains and Tdt: report of a unique case and review of the literature Pathology 2009 ;41(5):495-498
Nand,S.; Godwin,J.; Smith,S.; Barton,K.; Michaelis,L.; Alkan,S.; Veerappan,R.; Rychlik,K.; Germano,E.; Stiff,P.Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial Leukemia & lymphoma 2008 ;49(11):2141-2147
Levey,S. A.; Bajwa,R. S.; Picken,M. M.; Clark,J. I.; Barton,K.; Leehey,D. J.Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation. NDT Plus 2008 ;3:154-156
Levitt,M. R.; Benedict,W. J.; Barton,K.; Melian,E.; Gamelli,R. L.; Vandevender,D.; Rosseau,G.; Prabhu,V. C.Management of scalp toxic epidermal necrolysis and cranial osteomyelitis with serratus anterior myocutaneous pedicle flap: a case report. Journal of Burn Care & Research 2007 ;28(3):524-529
Garcia,T.; Dafer,R. M.; Hocker,S.; Schneck,M.; Barton,K.; Biller,J.Recurrent strokes in two patients with POEMS syndrome and Castleman's disease. Journal of Stroke & Cerebrovascular Diseases 2007 ;16(6):278-284
Kapur,U.; Barton,K.; Fresco,R.; Leehey,D. J.; Picken,M. M.Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Archives of Pathology & Laboratory Medicine 2007 ;131(9):1368-1372
Nand,S.; Barton,K.Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge Leukemia & lymphoma 2007 ;48(2):215-216
Naeem,M.; Harrison,K.; Barton,K.; Nand,S.; Alkan,S.A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy. European journal of haematology 2006 ;76(2):164-166
Wang,D.; John,S. A.; Clements,J. L.; Percy,D. H.; Barton,K. P.; Garrett-Sinha,L. A.Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease International immunology 2005 ;17(9):1179-1191
Geng,Y.; Laslo,P.; Barton,K.; Wang,C. R.Transcriptional regulation of CD1D1 by Ets family transcription factors Journal of immunology (Baltimore, Md.: 1950) 2005 ;175(2):1022-1029
Houde,C.; Li,Y.; Song,L.; Barton,K.; Zhang,Q.; Godwin,J.; Nand,S.; Toor,A.; Alkan,S.; Smadja,N. V.; Avet-Loiseau,H.; Lima,C. S.; Miele,L.; Coignet,L. J.Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood 2004 ;104(12):3697-3704
Khan,S. B.; Maududi,T.; Barton,K.; Ayers,J.; Alkan,S.Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma. British journal of haematology 2004 ;125(2):156-161